Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland 2020-03-11 08:00
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19 2020-02-25 21:30
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321 2020-02-24 08:00
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader 2020-02-18 18:42
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader 2020-02-18 18:18
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak 2020-02-12 08:00
WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak 2020-01-29 10:44
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus 2020-01-29 10:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany 2020-01-16 10:39
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases 2020-01-09 17:10
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392 2020-01-02 08:08
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters 2019-12-23 16:26
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland 2019-11-23 01:55
WuXi Biologics Reports Outstanding Interim Results 2019-08-19 22:09
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing 2019-06-21 08:39
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract 2019-05-21 07:30
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu 2019-05-16 15:39
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection 2019-04-17 09:14
WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs 2019-04-16 20:00
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership 2019-04-09 08:36
1 5 6 7 8 9 10